Have you listened to Paul's comment in the GRAFA interview?
https://grafa.com/news/paradigm-biopharma--asx-par--pursuing-fda-review-247123
Clearest indication yet they're waiting to sign!! (....my comment: Term Sheets may need to be updated once FDA confirms P3 protocol, including timeframes).
It may still NOT happen, however, there is more chance than ever before that it WILL.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-60
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
0.010(4.08%) |
Mkt cap ! $89.19M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 26.0¢ | 24.5¢ | $65.17K | 254.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 64000 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 14407 | 2 |
View Market Depth
| Last trade - 16.10pm 01/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |